Abbott Laboratories (ABT) Net Margin (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Net Margin data on file, last reported at 9.65% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin fell 314.0% year-over-year to 9.65%; the trailing twelve-month figure through Mar 2026 stood at 13.91% (down 1798.0% YoY), and the FY2025 full-year result was 14.72%, down 1723.0% from the prior year.
• Net Margin fell to 9.65% in Q1 2026, from 15.5% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 84.1% in Q4 2024 to a low of 9.65% in Q1 2026.
• A 5-year average of 18.37% and a median of 14.16% in 2023 frame the typical range for Net Margin.
• Across the five-year window, Net Margin jumped 6853 bps in 2024 and tumbled 6860 bps in 2025, its largest moves.
• Tracing ABT's Net Margin over 5 years: stood at 10.24% in 2022, then soared by 52 bps to 15.56% in 2023, then jumped by 440 bps to 84.1% in 2024, then slumped by 82 bps to 15.5% in 2025, then sank by 38 bps to 9.65% in 2026.
• Business Quant data shows ABT's Net Margin at 9.65% in Q1 2026, 15.5% in Q4 2025, and 14.46% in Q3 2025.